AveXis, Inc.
(NASDAQ : AVXS)

( )
AVXS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen, Inc.
0.12%282.621.4%$842.70m
AMGNAmgen, Inc.
-0.09%220.671.3%$515.31m
CELGCelgene Corp.
-0.64%109.321.3%$463.79m
GILDGilead Sciences, Inc.
-1.20%64.291.0%$395.55m
VRTXVertex Pharmaceuticals, Inc.
0.10%210.001.9%$314.19m
ILMNIllumina, Inc.
0.22%306.673.5%$312.01m
REGNRegeneron Pharmaceuticals, Inc.
-1.36%340.192.6%$264.05m
EXASEXACT Sciences Corp.
0.13%82.1624.0%$210.06m
ALXNAlexion Pharmaceuticals, Inc.
-0.37%107.972.0%$179.14m
SGENSeattle Genetics, Inc.
0.85%115.736.1%$138.13m
BMRNBioMarin Pharmaceutical, Inc.
0.17%75.174.3%$123.85m
SRPTSarepta Therapeutics, Inc.
0.45%97.9014.6%$115.90m
AAgilent Technologies, Inc.
-0.38%77.961.6%$100.97m
NBIXNeurocrine Biosciences, Inc.
1.41%114.645.0%$91.68m
BGNEBeiGene Ltd.
-1.13%196.012.1%$87.64m

Company Profile

Based in Dallas, Texas, AveXis is a clinic-ready, synthetic biology platform company. AveXis has, at its core, a desire to establish unique industry and research alliances which will bring innovative treatments to people with unmet medical needs. Our work in spinal muscular atrophy (SMA), a rare/orphan disease, is our first focus.